Dr. Amaka Eneanya discusses the push for race-neutral kidney care and how eGFR changes are advancing equity for Black patients.
This episode of Kidney Health Connections sheds light on systemic disparities in kidney care and the critical shift toward a race-neutral estimated glomerular filtration rate (eGFR) equation. Dr. Amaka Eneanya, adjunct professor of medicine at Emory University School of Medicine, discusses the historical use of race in the original eGFR equation, which disproportionately affected Black patients by assigning them higher kidney function levels based solely on race. This flawed approach led to delays in diagnoses, restricted access to nephrology care, and postponed eligibility for kidney transplants.
Dr. Eneanya helped lead the charge for the adoption of a race-neutral eGFR equation. In this discussion, she highlights the positive impact of this change on early intervention and access to treatment for Black Americans. She also shares actionable steps for labs, health plans, and providers to continue to drive adoption of race-neutral kidney disease testing and treatment.
Learn why the shift to a race-neutral eGFR equation matters and how it’s reshaping kidney care. Watch the full episode now.
You can also watch all episodes of the podcast on our YouTube channel—be sure to subscribe and never miss an update!
Follow Us
Presented by Interwell Health
www.interwellhealth.com